Burning mouth syndrome. Other and unspecified lesions of oral mucosa
Conditions
Interventions
Intervention 1: Intervention group 1: The drug given to all patients is citalopram, the initial dose of which is 10 mg and after one week it is increased to 20 mg and used once a day for one month an
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients are diagnosed with burning mouth syndrome. Patients are systemically healthy. Patients with normal oral mucosa should be examined clinically. Patients have a burning sensation daily 4 to 6 months with constant or increased intensity during the day.
Exclusion criteria
Exclusion criteria: Patients with systemic problems manifested by burning mouth, such as diabetes, severe anemia, vitamin deficiency. There are contraindications to laser administration such as pregnancy, epilepsy, cancer, chemotherapy. Patients with severe psychiatric disorders, such as major depression
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of mouth burning is measured by asking the patient using a 0 to 10 graduated ruler. Timepoint: The severity of burning will be measured before the start of treatment and at the end of each week after treatment (first week, second week, third week, fourth week) and the end of the third month. Method of measurement: Patient questions are measured using the Visual Analogue Scale, a scale from 0 to 10. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHooman Ebrahimi
Islamic Azad University
Outcome results
None listed